Gland Pharma Allots 44,193 Equity Shares Under ESOP Schemes
Gland Pharma Ltd 路 Others (Uncategorized) 路 13 Sept 2026, 9:09 pm
Gland Pharma Allots 44,193 Equity Shares Under ESOP Schemes Gland Pharma Limited allotted 44,193 equity shares of face value Re. 1 each on 13th Sep'26 upon the exercise of employee stock options. This includes 42,393 shares allotted to 35 employees under ESOP 2025 and 1,800 shares to one employee under ESOP 2019. Consequently, the company's paid-up share capital increased to Rs. 165,010,854 comprising 165,010,854 equity shares. Additionally, the ESOP Compensation Committee approved the formal closure and winding up of the ESOP 2019 scheme with immediate effect as all eligible options have been fully exercised or lapsed.
Original exchange filing (PDF)
More announcements from Gland Pharma Ltd
- Schedule of Investor Meet Intimation 路 17 Nov 2026
- Allotment of 3739 Equity Shares on exercise of ESOPs 路 16 Nov 2026
- Grant of Options to Purchase Securities 路 16 Nov 2026
- Q2FY27 Earnings Call Transcript 路 12 Nov 2026
- Gland Pharma Limited has issued Corporate Guarantee on behalf of Phixen SAS, wholly owned step down subsidiary of the Company 路 12 Nov 2026
- Appointment of Mr. Xiao Le as Chief Investment Officer at Gland Pharma International Pte. Ltd, wholly owned subsidiary of Gland Pharma Limited, effective November 09, 2026 路 09 Nov 2026
- Q2FY27 Earnings Call Recording 路 07 Nov 2026
- Q2Fy27 Investors presentation 路 06 Nov 2026
